CGC240719C12000
- 0.01
- -0.01-50.00%
Canopy Growth Newsroom
Piper Sandler Reaffirms Their Sell Rating on Canopy Growth (CGC)
Canopy Gwth Analyst Ratings
Piper Sandler Maintains Canopy Growth at Underweight, Cuts Price Target to US$2.00 on Weak Sales
Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Canopy Growth (CGC) and BioMarin Pharmaceutical (BMRN)
Analysts Conflicted on These Healthcare Names: Canopy Growth (CGC), Ultragenyx Pharmaceutical (RARE) and Roivant Sciences (ROIV)
Canopy Growth Sell Rating Justified by Stagnant Sales, High Valuation, and Profitability Concerns
Canopy Growth's (TSE:WEED) US Invasion Falls Flat With Shareholders
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Cogent Biosciences (COGT) and Canopy Growth (CGC)
Jefferies Sticks to Its Hold Rating for Canopy Growth (CGC)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bruker (BRKR), Canopy Growth (CGC) and Medtronic (MDT)
Piper Sandler Maintains Underweight on Canopy Gwth, Lowers Price Target to $3
Piper Sandler Sticks to Its Sell Rating for Canopy Growth (CGC)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Canopy Growth (CGC) and Vertex Pharmaceuticals (VRTX)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN) and Canopy Growth (CGC)
Canopy Growth's Stock Faces Sell Rating Amid Lower Sales, Regulatory Challenges, and Legal Risks
Analysts Conflicted on These Healthcare Names: Trulieve Cannabis (OtherTCNNF), Rallybio (RLYB) and Canopy Growth (CGC)
Canopy Growth Price Target Raised to $0.50 at CIBC
Analysts Conflicted on These Healthcare Names: Addus Homecare (ADUS), Axonics Modulation Technologies (AXNX) and Canopy Growth (CGC)
Tilray a Top Pick in Seeking Alpha's Quant Ratings Despite Short Interest
Bernstein Remains a Hold on Canopy Growth (CGC)